Serum sulfatide level is associated with severe systemic vasculitis with kidney involvement.

kidney injury rapidly progressive glomerulonephritis sphingolipids sulfatides vasculitis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 02 08 2023
accepted: 17 11 2023
medline: 19 12 2023
pubmed: 19 12 2023
entrez: 19 12 2023
Statut: epublish

Résumé

Sulfatides are a type of sulfated glycosphingolipid that are secreted with lipoproteins into the serum. These molecules are involved in the inflammatory pathway of vessels in addition to coagulation and platelet aggregation. Previous studies have proposed that sulfatides play a pivotal role in regulating inflammation-related disorders. Systemic vasculitis (SV) diseases are generally caused by autoimmune diseases and often involve kidney vasculitis, which may lead to rapidly progressive kidney dysfunction and end-stage kidney disease. Our earlier pilot study revealed that the level of serum sulfatides (SSs) was significantly decreased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), a representative disease-causing SV with kidney involvement (SVKI), especially in patients exhibiting active crescentic findings on kidney biopsy. To further explore the clinical significance of an association between SS and SVKI, we analyzed and compared the SS level of patients with various SVKI diseases in this retrospective cohort study. Among patients admitted to our hospital between 2008 and 2021, we ultimately enrolled 26 patients with IgA vasculitis (IgAV), 62 patients with AAV, and 10 patients with anti-glomerular basement membrane disease (GBM) as examples of SVKI diseases, as well as 50 patients with IgA nephropathy (IgAN) and 23 donors for living kidney transplantation as controls. The mean ± standard deviation SS level in the donor, IgAN, IgAV, AAV, and GBM groups was 8.26 ± 1.72, 8.01 ± 2.21, 6.01 ± 1.73, 5.37 ± 1.97, and 2.73 ± 0.99 nmol/mL, respectively. Analysis of patients in the SVKI disease group showed that those with the crescentic class kidney biopsy finding exhibited a significantly lower SS level than did those with other class biopsy features. Additionally, the SS level had a higher detection ability for SVKI patients with crescentic class kidney biopsy findings (area under the receiver operating characteristic curve 0.90, 95% confidence interval 0.82-0.99) than did several other predictor candidates. Our results indicate that the SS level is decreased in more severe SVKI diseases and may be associated with active glomerular lesions in SVKI kidney biopsy samples.

Identifiants

pubmed: 38111574
doi: 10.3389/fimmu.2023.1271741
pmc: PMC10726124
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1271741

Informations de copyright

Copyright © 2023 Aomura, Harada, Nakajima, Nimura, Yamaka, Yamada, Hashimoto, Tanaka and Kamijo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Daiki Aomura (D)

Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Japan.

Makoto Harada (M)

Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Japan.

Takero Nakajima (T)

Department of Metabolic Regulation, Shinshu University School of Medicine, Matsumoto, Japan.
Center for Medical Education and Training, Shinshu University School of Medicine, Matsumoto, Japan.

Takayuki Nimura (T)

Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Japan.

Kosuke Yamaka (K)

Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Japan.

Yosuke Yamada (Y)

Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Japan.

Koji Hashimoto (K)

Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Japan.

Naoki Tanaka (N)

Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Japan.
International Relations Office, Shinshu University School of Medicine, Matsumoto, Japan.
Research Center for Social Systems, Shinshu University, Matsumoto, Japan.

Yuji Kamijo (Y)

Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Japan.

Classifications MeSH